Discovery of novel N-β-D-xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes.

Citation: Yao CH, Song JS, Chen CT, Yeh TK, Hung MS, Chang CC, Liu YW, Yuan MC, Hsieh CJ, Huang CY, Wang MH, Chiu CH, Hsieh TC, Wu SH, Hsiao WC, Chu KF, Tsai CH, Chao YS, Lee JC.: Discovery of novel N-β-D-xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes. J Med Chem, Volume 54 (1), 2011
Authors: Chang CC, Chao YS, Chen CT, Chiu CH, Chu KF, Hsiao WC, Hsieh CJ, Hsieh TC, Huang CY, Hung MS, Lee JC., Liu YW, Song JS, Tsai CH, Wang MH, Wu SH, Yao CH, Yeh TK, Yuan MC
Journal: J Med Chem
Year: 2011
DOI: 10.1021/jm101072y
PubMed: 21128592
Machine-readable: REST API RDF

Publication